Commemorating 100 Years of Biologics Regulation
Public Symposium
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Public Symposium - 9/23-24/2002 -
(PDF),
(Text)
Change in location to NIH, Warren Grant Magnuson Clinical Center, Building 10 -
(PDF),
(Text)
Symposium Agenda - (PDF), (Text)
FDA Science Symposium on Biological Products -Press Office Note to Correspondents - 9/19/2002
Slide Presentations
- CBER Centennial: Opening Presentation
Kathryn C. Zoon, Ph.D. - (PDF), (Text) - Harry Meyer, Jr., MD Lecture
Paul Parkman, M.D. (Text) - International Biologics Issues
Professor Dr. med Johannes Löwer - (PDF), (Text) - Issues in Blood Research
Jay S. Epstein, M.D. - (PDF), (Text) - "Raise the Standards"
David Aronson, M.D. - (PDF), (Text) - "A Bloody Odyssey"
John Petricciani, M.D. - (PDF), (Text) - "TSEs: BSE, CJD, vCJD and the Blood Supply"
David Asher, M.D. - (PDF), (Text) - Issues in Vaccines Research: The Biologics Control Act of 1902 and the Regulation of Biologics: A Brief Reflection
William M. Egan, Ph.D. - (PDF), (Text) - Development of Methods for Evaluation of Live Viral Vaccines
Konstantin Chumakov, Ph.D., D.Sc. - (PDF), (Text) - New Efforts in Counter-Bioterrorism
Anthony S. Fauci, M.D. - (Part 1 - PDF), (Part 2 - PDF), (Part 3 - PDF),
(Part 4 - PDF), (Part 5 - PDF) - CBER Centennial: Issues in Therapeutics Research
Jay P. Siegel, M.D. - (PDF), (Text) - Issues in Therapeutics Research/Future Technology
Emmanuel F. Petricoin, Ph.D - (Part 1 - PDF), (Part 2 - PDF), (Part 3 - PDF),
(Part 4 - PDF), (Part 5 - PDF), (Part 6 - PDF) - CBER Centennial: Closing Presentation - Future Challenges in Biologics
Kathryn C. Zoon, Ph.D. - (PDF), (Text)